Ludovic Ferrer
Ludovic Ferrer
ICO René Gauducheau
Verified email at
Cited by
Cited by
GATE: a simulation toolkit for PET and SPECT
S Jan, G Santin, D Strul, S Staelens, K Assie, D Autret, S Avner, R Barbier, ...
Physics in Medicine & Biology 49 (19), 4543, 2004
Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [18F]Fluorodeoxyglucose Positron Emission Tomography
C Rousseau, A Devillers, C Sagan, L Ferrer, B Bridji, L Campion, ...
Journal of clinical oncology 24 (34), 5366-5372, 2006
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization …
F Kraeber-Bodéré, C Rousseau, C Bodet-Milin, L Ferrer, ...
Journal of Nuclear Medicine 47 (2), 247-255, 2006
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial
F Kraeber-Bodéré, S Bardet, CA Hoefnagel, MR Vieira, JP Vuillez, ...
Clinical cancer research 5 (10), 3190s-3198s, 1999
ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine
F Haddad, L Ferrer, A Guertin, T Carlier, N Michel, J Barbet, JF Chatal
European Journal of Nuclear Medicine and Molecular Imaging 35 (7), 1377-1387, 2008
Nuclear medical imaging using β+ γ coincidences from 44Sc radio-nuclide with liquid xenon as detection medium
C Grignon, J Barbet, M Bardiès, T Carlier, JF Chatal, O Couturier, ...
Nuclear Instruments and Methods in Physics Research Section A: Accelerators …, 2007
High frequency of bone/bone marrow involvement in advanced medullary thyroid cancer
E Mirallie, JP Vuillez, S Bardet, E Frampas, B Dupas, L Ferrer, ...
The Journal of Clinical Endocrinology & Metabolism 90 (2), 779-788, 2005
Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT
T Carlier, T Eugène, C Bodet-Milin, E Garin, C Ansquer, C Rousseau, ...
EJNMMI research 3 (1), 1-12, 2013
Monte Carlo modeling of gamma cameras for I-131 imaging in targeted radiotherapy
D Autret, A Bitar, L Ferrer, A Lisbona, M Bardiès
Cancer biotherapy & radiopharmaceuticals 20 (1), 77-84, 2005
Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen× anti-hapten bispecific antibody-mediated pretargeting of iodine-131-labeled hapten in …
F Kraeber-Bodéré, A Faivre-Chauvet, L Ferrer, JP Vuillez, PY Brard, ...
Clinical cancer research 9 (10), 3973s-3981s, 2003
Effect of patient morphology on dosimetric calculations for internal irradiation as assessed by comparisons of Monte Carlo versus conventional methodologies
A Divoli, S Chiavassa, L Ferrer, J Barbet, GD Flux, M Bardies
Journal of Nuclear Medicine 50 (2), 316-323, 2009
Radioimmunoconjugates for the treatment of cancer
F Kraeber-Bodéré, C Bodet-Milin, C Rousseau, T Eugène, A Pallardy, ...
Seminars in oncology 41 (5), 613-622, 2014
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients
C Rousseau, A Devillers, M Campone, L Campion, L Ferrer, C Sagan, ...
European journal of nuclear medicine and molecular imaging 38 (6), 1029-1036, 2011
Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients
C Rousseau, L Ferrer, S Supiot, M Bardiès, F Davodeau, ...
Tumor Biology 33 (3), 679-688, 2012
Voxeldose: a computer program for 3-D dose calculation in therapeutic nuclear medicine
I Gardin, LG Bouchet, K Assié, J Caron, A Lisbona, L Ferrer, WE Bolch, ...
Cancer Biotherapy and Radiopharmaceuticals 18 (1), 109-115, 2003
Prospective comparison of 3 γ-probes for sentinel lymph node detection in 200 breast cancer patients
JM Classe, M Fiche, C Rousseau, C Sagan, F Dravet, R Pioud, A Lisbona, ...
Journal of Nuclear Medicine 46 (3), 395-399, 2005
Comparison of electron dose-point kernels in water generated by the Monte Carlo codes, PENELOPE, GEANT4, MCNPX, and ETRAN
H Uusijärvi, N Chouin, P Bernhardt, L Ferrer, M Bardies, ...
Cancer biotherapy and radiopharmaceuticals 24 (4), 461-467, 2009
Implementing dosimetry in GATE: Dose-point kernel validation with GEANT4 4.8. 1
L Ferrer, N Chouin, A Bitar, A Lisbona, M Bardiès
Cancer biotherapy & radiopharmaceuticals 22 (1), 125-129, 2007
Single-dose anti-CD138 radioimmunotherapy: bismuth-213 is more efficient than lutetium-177 for treatment of multiple myeloma in a preclinical model
N Fichou, S Gouard, C Maurel, J Barbet, L Ferrer, A Morgenstern, ...
Frontiers in medicine 2, 76, 2015
Radioimmunotherapy of B-cell non-Hodgkin’s lymphoma
C Bodet-Milin, L Ferrer, A Pallardy, T Eugène, A Rauscher, ...
Frontiers in oncology 3, 177, 2013
The system can't perform the operation now. Try again later.
Articles 1–20